This inventor holds 2 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent. Top assignees: Evonik Rohm Gmbh, Merck Patent Gmbh. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: The Innovative Contributions of Marc Schneider
Introduction
Marc Schneider is a notable inventor based in Saarbruecken, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel microparticle formulations. With a total of 2 patents to his name, Schneider's work focuses on enhancing drug delivery systems through innovative processes.
Latest Patents
One of Schneider's latest patents is titled "Preparation of nanoparticles-releasing enteric microparticles." This invention outlines a process for creating enteric microparticles that incorporate nanoparticles, which consist of a matrix and an active ingredient. The resulting microparticles are applicable in various multiparticulate pharmaceutical formulations, including extemporaneous dosage forms such as powders for reconstitution.
Another significant patent by Schneider is the "Process for preparing poly(glycolide-co-lactide) copolymer microparticles." This process involves preparing poly(lactide-co-glycolide) copolymer particles with an average size ranging from 50 to 800 nm. The method includes transferring a mixture of the copolymer, ethanol, and carbon dioxide from one reactor to another, leading to phase separation and the formation of an ethanolic suspension or dry form of the copolymer particles.
Career Highlights
Throughout his career, Marc Schneider has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Patent GmbH and Evonik Röhm GmbH. His experience in these organizations has contributed to his expertise in the field of drug delivery systems and microparticle technology.
Collaborations
Schneider has collaborated with several professionals in his field, including Andrea Hanefeld and Markus Weigandt. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical formulations.
Conclusion
Marc Schneider's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of advanced drug delivery systems, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile